References
- Johnson S M, Mauritson D R, Corbett J R, et al. Double-blind, randomized, placebo-controlled comparison of propranolol and verapamil in the treatment of patients with stable angina pectoris. Am J Med 1981; 71: 443–51
- Bonow R O, Leon M B, Rosing D R, et al. Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise. Circulation 1981; 65(7)1337–50
- Zanolla L, Trevi G P, Rizzo A, et al. Long-term persistence or antianginal effect of oal verapamil in chronic stable angina. J Cardiovasc Pharmacol 1984; 6: 423–8
- Frishman W H, Klein N A, Strom J A, et al. Superiority of verapamil to propranolol in stable angina pectoris, a double-blind, randomized crossover study. Circulation 1982; 65(1)1-51–1-59
- Amman K, Ryden L, et al. Comparison of metoprolol and verapamil in the treatment of angina pectoris. Am J Cardiol 1982; 49: 821–7
- Bowles M J, Subramanlan V B, Davies A B, et al. Double-blind randomized crossover trial of verapamil and propranolol in chronic stable angina. Am Heart J 1983; 106: 1297–306
- Brodsky S J, Cutler S S, Weiner D A, et al. Treatment of stable angina of effort with verapamil: a double-blind, placebo-controlled randomized crossover study. Circulation 1982; 66(3)569–77
- Johnston D L, Manyarl D E, Kostuk W J. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris. Can Med Assoc J 1984; 130: 1449–55
- Pine M B, Citron P D, Bailly D J, et al. Verapamil versus placebo in relieving stable angina pectoris. Circulation 1982; 65(1)17–22
- Sadick N N, Tan A T H, Fletcher P J, et al. A double-blind randomized trial of propranolol and verapamil in the treatment of effort angina. Circulation 1982; 66(3)574–9
- Weiner D A, Klein M D. Verapamil therapy for stable exertional angina pectoris. Am J Cardiol 1982; 50: 1153–7
- Weiner D A, Klein M D, Cutler S S. Efficacy of sustained-release verapamil in chronic stable angina pectoris. Am J Cardiol 1987; 59: 215–8
- Subramanian W B, Bowles M J, Lahiri A, et al. Long-term antianginal action of verapamil assessed with quantitated serial treadmill stress testing. Am J Cardiol 1981; 48: 529–35
- Southall E, Nutt N R, Thomas R D. Chronic stable angina: Comparison of verapamil and propranolol. J Int Med Res 1982; 10: 361–6
- Weiner D A, McCabe C H, Cutler S S, et al. Plasma verapamil levels and exercise performance. Clin Pharmacol Ther 1984; 36: 25–32
- Kokkonen P, Haataja H, Wartiovaara E. Analytical validation data for research 13127. 1989, Study Report, Orion Pharmaceutica, Research Center, Espoo, Finland
- Romppanen T, Haataja H, Wartiovaara E. Determination of verapamil and norverapamil in human serum by capillary gas chromatography-mass spectrometry. Orion Pharmaceutica, Research Center, EspooFinland 1989
- Roubin G S, Sadick N A, Anderson S D, et al. Effect of propranolol and verapamil on oxygen utilization, acidosis and fatigue during exercise in stable angina pectoris. Am J Cardiol 1987; 60: 249–55